Ignite Creation Date:
2025-12-24 @ 9:57 PM
Ignite Modification Date:
2025-12-28 @ 2:28 AM
Study NCT ID:
NCT00637832
Status:
TERMINATED
Last Update Posted:
2022-01-06
First Post:
2008-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed Follicular Non-Hodgkin Lymphoma
Sponsor:
University of Southampton
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2015-01-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-01-06
Completion Date Type:
ACTUAL
First Submit Date:
2008-03-14
First Submit QC Date:
None
Study First Post Date:
2008-03-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-16
Last Update Post Date:
2022-01-06
Last Update Post Date Type:
ACTUAL